Targeting the central nervous system: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123.

MLA

Tosi, G., et al. “Targeting the Central Nervous System: In Vivo Experiments with Peptide-Derivatized Nanoparticles Loaded with Loperamide and Rhodamine-123.” Journal of Controlled Release : Official Journal of the Controlled Release Society, vol. 122, no. 1, Sept. 2007, pp. 1–9. EBSCOhost, https://doi.org/10.1016/j.jconrel.2007.05.022.

APA

Tosi, G., Costantino, L., Rivasi, F., Ruozi, B., Leo, E., Vergoni, A. V., Tacchi, R., Bertolini, A., Vandelli, M. A., & Forni, F. (2007). Targeting the central nervous system: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123. Journal of Controlled Release : Official Journal of the Controlled Release Society, 122(1), 1–9. https://doi.org/10.1016/j.jconrel.2007.05.022

Chicago

Tosi, G, L Costantino, F Rivasi, B Ruozi, E Leo, A V Vergoni, R Tacchi, A Bertolini, M A Vandelli, and F Forni. 2007. “Targeting the Central Nervous System: In Vivo Experiments with Peptide-Derivatized Nanoparticles Loaded with Loperamide and Rhodamine-123.” Journal of Controlled Release : Official Journal of the Controlled Release Society 122 (1): 1–9. doi:10.1016/j.jconrel.2007.05.022.